The US government procures goods and services subject to a complex web of laws and regulations. These requirements are also a key part of President Donald J. Trump’s “America First” platform. Non-US companies seeking to bid on US government contracts – including pharmaceutical companies manufacturing their products abroad for importation into the US – must understand how these laws may affect their efforts to enter this lucrative market, while at the same time monitoring political developments in Washington DC.